Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on ...

Public health, access to healthcare services, and food and nutrition are some of the most important issues facing people ...

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges ...

The British Skin Foundation’s (BSF) skin research programme has received a £10,000 donation from Circle Health Group (CHG) ...

Many initiatives have tried to address this partnership challenge: the Healthcare Communications Association’s (HCA) own ...

Yesterday marked World Heart Day, and Medscape is at the forefront with a featured article in Media Planet's cardiology ...

This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, ...

Astellas Pharma’s claudin 18.2-directed cytolytic antibody has been approved by the European Commission (EC) as part of a first-line combination treatment for a subset of gastric cancer patients.

AstraZeneca’s (AZ) Tagrisso (osimertinib) has been approved by the US Food and Drug Administration (FDA) to treat a new subset of lung cancer patients. The epidermal growth factor receptor ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been recommended by the European Medicines Agency’s human medicines committee to treat younger eosinophilic oesophagitis (EoE) patients. The Committee ...

Sanofi has shared positive results from a late-stage study of its investigational BTK inhibitor, tolebrutinib, in patients with non-relapsing secondary progressive multiple sclerosis (nrSPMS). The ...

The US Food and Drug Administration (FDA) has approved Zevra Therapeutics’ Miplyffa (arimoclomol) to treat Niemann-Pick disease type C (NPC), an ultra-rare lysosomal storage disorder affecting one in ...